Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03352206
Recruitment Status : Recruiting
First Posted : November 24, 2017
Last Update Posted : September 30, 2019
Case Western Reserve University
Ministere de la Sante Publique et de la Population, Haiti
Indonesia University
Papua New Guinea Institute for Medical Research
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019
World Health Organization. Monitoring and Epidemiological Assessment of Mass Drug Administration in Global Programme to Eliminate Lymphatic Filariasis: A Manual for National Elimination Programmes. Geneva: World Health Organization; 2011. Accessed October 11, 2017.
World Health Organization. Assessing the epidmiology of soil-transmitted helminths during a transmission assessment survey in the global programme for the elimination of lymphatic filariasis. 2015. Accessed October 12, 2017.